Advanced Inhalation to launch on NASDAQ

Israeli biotech Advanced Inhalation Therapies (AIT), plans to raise $12 million on NASDAQ. AIT (new name Beyond Air) develops products for the treatment of respiratory infections including Cystic Fibrosis. See previous newsletter articles (here) of its Nitric Oxide treatment.

http://www.globes.co.il/en/article-advanced-inhalation-therapies-set-for-12m-nasdaq-ipo-1001098247

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *